Monitoring and targeting protein kinases is widely accepted as a promising approach for disease diagnosis and drug discovery. For this purpose, the authors have developed an original type of peptide array as a high-throughput screening assay for quantitatively evaluating kinase activity. A volume of 2 nL of peptide solution was spotted onto a formyl group-modified glass slide by using an arrayer, which was designed for use with protein chip technology. The phosphorylation was recognized by fluorescence-label antibody and detected with an automatic microarray scanner widely used in DNA chip technology. The system needs low sample volume, provides a high-density peptide array, and supplies high reproducibility. It provided enough sensitivity for inhibitor screening, even though a relatively low concentration of purified kinase was employed. The assay also proved useful for the detection of intracellular kinase activity as well as for the measurement of the fluctuations of intracellular protein kinase activity with drug stimulation. Thus, this peptide array would be applicable for kinase-targeted diagnosis, cell-based drug screening, and signal pathway investigation. (Journal of Biomolecular Screening 2009:256-262) 
INTRODUCTION
P hOSphORyLATION By pROTeIN kINASeS plays a key role in cellular signal transduction and regulates many important intracellular processes, including cell growth, adhesion, proliferation, differentiation, and apotosis. 1 The abnormality and perturbation of protein kinase activity has been proven to be a cause or consequence of many diseases such as cancer, inflammation, and diabetes. Therefore, monitoring and targeting the activity of protein kinases is widely accepted as a promising approach for drug screening and disease diagnosis. 2 The traditional technologies for analyzing and detecting protein kinase activity such as filter-binding assays, gel-based assays, and enzyme-linked immunosorbent assays (eLISAs) are restricted by their low throughput and somewhat cumbersome procedures.
Recently, microarray systems have been developed as a promising approach for high-throughput screening (hTS) of kinase activity. 3 Compared with other hTS platforms for homogeneous assays such as deep quench, scintillation proximity, and colorimetric methods, the microarrays provide higher density probes and need lower sample volumes. More importantly, they can significantly reduce the interference of impurities through the use of extra steps such as blocking and washing. peptides will likely be more useful probes for microarrays than their comparable proteins because they are much more stable and easily prepared. The signal-readout approach of the microarray system is also shifted from hazardous autoradiography to simpler fluorescence imaging. In fact, several peptide microarrays using fluorescence have already been reported for the detection of protein kinase activity. [4] [5] [6] Although these peptide microarrays can be used to screen substrates or inhibitors of certain kinases using purified enzymes, most of them are not robust enough to detect the target protein kinase activity from a cell lysate containing various compounds. however, detecting this intracellular protein kinase activity is important for diagnosis, cellbased drug discovery, and elucidation of cell function.
We have been investigating a peptide array for use in highthroughput analysis of protein kinase activity based on fluorescence imaging. In a previous study, we successfully detected the activity of protein kinase A and c-Src in cell lysates 7 using a glass slide that accommodates 570 reaction wells (1 mm in diameter), thus proving the feasibility of our system to the cell lysate. however, the former system was restrained from the low density of reaction wells, which is not enough to achieve high throughput, and the investigations of the intracellular kinase activities, which involved only 1 cell line and 1 drug compound did not fully elucidate the applicability of the peptide array to the drug screening and diagnosis. In the present study, to raise the density and robustness of the peptide array, we replaced the well-based glass slide with a planar glass slide and introduced an arrayer machine designed for protein chip technology to deliver 2 nL of peptide solution for immobilization. As a result, the new system needs a much lower sample volume (1/250 of that used previously), provides a 10 times higher density of peptide spot, and supplies higher reproducibility (Z′ = 0.71). We applied the new system to detect c-Src activity in different cell lines as well as mouse tissues. Moreover, we succeeded in monitoring small fluctuations of c-Src activity responding to various drug stimuli. These results demonstrate that the sensitive and robust peptide array should be applicable for kinasetarget diagnosis, cell-based drug screening, and signal pathway research.
MATERIALS AND METHODS

Reagents
The planar amino-terminal glass slide was purchased from Matsunami Glass (Osaka, Japan). c-Src was obtained from Carna Bioscience (kobe, Japan). Cy5 anti-phosphotyrosine antibody, pp2, and SU6656 were purchased from Amersham Biosciences (Chalfont St. Giles, Bucks, Uk). phorbol 12-myristate 13-acetate (pMA) was obtained from Sigma (St. Louis, MO). Nerve growth factor (NGF) was purchased from Invitrogen (Carlsbad, CA). The Bradford reagent was purchased from Bio-Rad Laboratories Inc. (hercules, CA).
Preparation of a peptide array
To evaluate the extent of peptide phosphorylation, a c-Src substrate that had a prephosphorylated tyrosine in the peptide sequence was chosen as the positive control, and the negative control had a phenylalanine in the phosphorylation site ( Table 1) . Cysteine was introduced at the N-terminal to serve as a functional group, which could be tethered to the glass slide, and 2 spacers of X (X = 8-amino-3, 6-dioxaoctanoic acid) were added between the cysteine and the peptide to distance the peptide away from the glass slide surface.
All peptides were synthesized following the steps described in our previous study. 7 The amino-terminal glass slide was reacted with 1% glutaraldehyde in aqueous NahCO 3 solution (50 mM, ph 9.5) for 2 h at 37 °C. The slide was rinsed 2 times with pure water for 8 min with sonication, and 2 nL of the substrate peptides having a cysteine at the N-terminus (50 µM) were spotted in a 20-µL aqueous NahCO 3 solution (50 mM, ph 9.5) containing 50 µM tris(carboxyethyl)phosphine onto the slide with an automatic arrayer (kaken Genetics, Chiba, Japan) using a φ150-µm pin, and the slide was incubated overnight at room temperature. After peptide immobilization, the slide was rinsed 2 times with 25 mM Tris-buffered saline containing 0.05% Tween 20 (TBS-T) for 8 min with sonication and blocked for 1 h using Blocking One-p (Nacalai Tesque, Tyoto, Japan), which contains bovine serum albumin (BSA) and some kind of polymer, in TBS-T buffer at room temperature to reduce nonspecific adsorption from the following phosphorylation reaction.
On-chip phosphorylation and detection
The immobilized peptides were phosphorylated by purified c-Src or cell lysate in a solution containing 15 mM Tris/hCl (ph 7.5), 5 mM MgCl 2 , and 0.1 mM ATp at 37 °C. To determine the optimal enzyme concentration, 0, 10, or 30 ng/mL of c-Src was used and the phosphorylation was performed for 90 min. For the monitoring of the reaction time course, 30 ng/mL of c-Src was used, and the phosphorylation ratio was determined after 0, 30, 60, 90, and 120 min after the c-Src addition. The inhibitor screening experiments were performed using the initial linear range of the time course. All the lysates used in the experiments were 100 µg/mL, and the reaction times were 2 h. After the phosphorylation reaction, the slide was rinsed 3 times with TBS containing 1% sodium dodecyl sulfate (SDS) for 8 min with sonication and then rinsed with pure water without sonication. The slide was treated with 3.3 µg/mL Cy5-labeled antiphosphotyrosine antibody in TBS-T and was incubated for 20 min at room temperature. The slide was then rinsed for 5 min with TBS-T with sonication, subsequently rinsed with pure water, and dried under a nitrogen stream. Finally, the fluorescence signal was analyzed with a laser array scanner (packard BioScience Scan Array Light; packard Bioscience, Billerica, MA).
Preparation of cell/tissue lysates
MCF-7 breast cancer cells were cultured in minimum essential medium (MeM) supplemented with 10% fetal bovine serum 
The underlined amino acid indicates the phosphorylation site.
(FBS), 1% antibiotic-antimycotic, 1% MeM nonessential amino acids, and 1% insulin-transferrin-selenium-A in a humidified atmosphere containing 5% CO 2 at 37 °C. The media were then replaced by serum-free MeM and incubated for 18 h before lysis or drug stimulation. To inhibit the intracellular c-Src activity, the cells were treated for 2 h with serum-free media containing different concentrations of c-Src-specific inhibitor (pp2 or SU6656). For the activation of the intracellular c-Src, the cells were treated with 10 nM pMA in serum-free media for 20 min or with 100 ng/mL NGF in serum-free media for 10 min, and the final concentrations of DMSO, which was used to dissolve the reagents, were all 0.1%, at which the toxicity of DMSO is negligible. After stimulation, the cells were washed twice with Dulbecco's phosphate-buffered saline (-) (D-pBS) and collected by scraping. The collected cells were centrifuged at 1500 rpm for 5 min at 4 °C. The supernatant was removed, and the cells were resuspended in a lysis buffer containing 10 mM potassium phosphate (ph 7.25), 1 mM eDTA, 5 mM eGTA, 10 mM MgCl 2 , 2 mM dithiothreitol (DTT), 1 mM sodium orthovanadate, 80 mM β-glycerophosphate, 3 µg/mL pepstatin A, 5 µg/mL aprotinin, and 1 mM phenylmethylsulfonyl fluoride (pMSF) and then sonicated 3 times for 15 s by a homogenizer (Branson, Danbury, CT) in an ice bath. The homogenate was centrifuged at 100,000g for 60 min, and the supernatant was collected as cytosol fractions. The remaining pellet was resuspended in the same lysis buffer containing 0.2% triton X-100 and sonicated 3 times for 15 s. The solution was centrifuged at 100,000g for 40 min, and the supernatant was collected and used as membrane fraction.
ChO and A431 cells were cultured in Dulbecco's minimum essential medium (D-MeM) supplemented with 10% FBS and 1% antibiotic-antimycotic. pC12 cells were cultured in RpMI-1640 supplemented with 10% FBS and 1% antibiotic-antimycotic. All the lysates were prepared in the same way as MCF-7 lysate.
Animal studies were all performed in accordance with the Guidelines for Animal experiments of kyushu University. Mice (5-wk-old male BALB/c) were killed, and the brain and skin were excised. All the lysates were prepared in the same way as the MCF-7 lysate.
All protein concentrations were determined using the Bradford reagent.
RESULTS AND DISCUSSION
high-throughput and robust evaluation of kinase activity is critical for kinase-related drug discovery or research on signal pathways. To improve the capacity for analysis of kinase activity, we replaced our former glass slide, which has 570 reaction microwells (1 mm in diameter), to a planar glass slide, which is modified by amino groups with high density. Using this system, the maximum spotting number can be increased from 570 to about 6000, and also the spotting volume can be reduced from 0.5 µL to 2 nL compared with the microwell system.
The method of on-chip phosphorylation detection is similar to that of our previous work. 7 Briefly, as shown in Figures 1A  and 1B , cysteine-terminal peptides are covalently immobilized onto the amino-terminal glass via a glutaraldehyde linker. After blocking the peptide-anchored glass slide, the peptides are phosphorylated by c-Src or cell lysate in the ATp-containing solution and treated with Cy5-labeled antiphosphortyrosine antibody. Finally, the on-chip phosphorylation was detected by an ordinary microarray scanner normally used in DNA chip technology. Figure 1C shows a typical fluorescence image of peptides in the presence or absence of on-chip phosphorylation. Substrate could be detected only after the c-Src treatment, whereas the on-chip phosphorylation reaction had no effect on the positive and negative controls.
To determine the extent of substrate phosphorylation, a phosphorylation ratio was calculated from the following equation. phosphorylation ratio (%) = (FI of substrate -FI of negative control)/(FI of positive control -FI of negative control), where FI represents the fluorescence intensity.
Detection linearity and array density
We determined the required concentration of the peptides for immobilization using the peptides of series 2 in Table 1 (2-py, 2-y, and 2-F). The fluorescence intensity of 2-py increased with concentrations up to 50 µM, after which it was saturated (see Supplemental Fig. 1A online at http://jbx.sagepub. com/supplemental/). This saturation was likely because the antibody could not recognize any additional epitopes due to steric hindrance. On the other hand, the fluorescence intensity of the 2-y and 2-F peptides remained constant. This result indicates that the fluorescence-labeled antiphosphotyrosine antibody can detect phosphorylated tyrosine peptides quantitatively on the glass plate below a 50-µM concentration. We next evaluated the linearity of peptide detection at less than 50 µM. Calibration experiments using different ratios of 2-py/2-y at a total peptide concentration of 20 or 50 µM were performed. Supplementary Figure 1B shows the fluorescence intensity of each combined peptide spot against its percentage of 2-py in the solution. The calibration lines obtained from both 20 and 50 µM of the total peptides show good linearities against the percentage of the phosphorylated peptide in the solutions. This demonstrates the good quantitative ability for peptide phosphorylation at less than 50 µM. Because of easy detection of the large change in fluorescence intensity when 50 µM of peptide is used, the concentrations of the immobilized peptides were determined to be 50 µM in the following experiments.
We checked the possibility of a high-density peptide array and the ability of the assay performance. eight hundred forty peptide spots (2-py, 2-y, and 2-F, each with 240 spots) were spotted on the glass using a 150-µm pin in a very narrow area of a slide. Figure 1C shows the layout of 840 spots on 1 slide. The diameter of 1 spot is about 250 µm, and the distance between 2 spots is 450 µm. With the spotting format, more than 6000 spots can be arrayed on 1 slide. To use a smaller pin and narrower distance, 10,000 spots could be arrayed. Supplementary Figure 1D is the fluorescence intensity of 840 spots shown in Supplementary Figure 1C . The Z′ factor, which is used to evaluate an assay performance 8 deduced from the fluorescence intensity of 2-py and 2-F, is 0.71. These results show the high density of the array and the high performance of the assay. 
Supplementary
Quantitative analysis of purified kinase activity
The reactivity of 1-y and 2-y to purified c-Src kinase was compared using various concentrations of c-Src (Supplementary Fig. 2A) . The 2-y peptide has higher sensitivity than 1-y for c-Src kinase. This result was supported by a former report that the optimal substrate for c-Src contains the sequence eeIyGeF. 9 Thus, peptides of series 2 were chosen and used in the following experiments. The reaction time course of the 2-y phosphorylation shows a time-dependent increase in the substrate phosphorylation ratio and a saturation of the phosphorylation ratio (100%) at 2 h ( Supplementary  Fig. 2B) . These results demonstrate that our peptide array can evaluate the kinase activity quantitatively and potentially be applicable to substrate screening.
We then tried to apply our peptide array to the inhibitor screening using a purifed kinase. Two c-Src-specific inhibitors, pp2 and SU6656, were chosen 10, 11 (Supplementary Fig. 2C) . The analysis of the inhibitory effect was conducted using the program Graphpad prism 4. Results indicated that pp2 and SU6656 inhibited c-Src activity. Congruent with previous reports, pp2 inhibited c-Src activity more strongly than SU6656 did. 10, 11 The IC 50 was determined to be 79 nM and 361 nM for pp2 and SU6656, respectively. These values are comparable with those of the previous reports (pp2, 100 nM; SU6656, 280 nM). This result suggests that our chip can be used for inhibitor screening using purified kinases.
Detection of intracellular kinase activity
The ability to detect intracellular kinase activity is crucial to elucidate cell function and is useful for disease diagnosis and cell-based drug screening. Thus, we tried to apply our peptide array to detect intracellular c-Src kinase activity. It was reported that c-Src is activated continuously in the human breast cancer cell MCF-7. 12 For the experiment, the cell lysate was prepared and divided into the cytosol and membrane fractions, then on-chip phosphorylation was performed using the cell lysate ( Fig. 2A) . When 2-y was phosphorylated by both the cytosol and membrane fractions, it seems that the membrane fraction had a much higher kinase activity. This result is reasonable because activated c-Src is mainly located near the cellular membrane. Thus, the membrane fractions were used in following experiments. To confirm that the phosphorylation of 2-y resulted from the intracellular c-Src, 50 µM pp2 or SU6656 was added into the cell lysate of the membrane fraction, and then on-chip phosphorylation was implemented (Fig. 2B) . Compared with the control lysate, which was free of inhibitor, the phosphorylation ratio of substrate was drastically suppressed by the addition of inhibitor to the lysate. This result indicated that 2-y has relatively high specificity to c-Src kinase, and it is possible to use 2-y as a probe for the direct detection of intracellular c-Src kinase activity. Interestingly, pp2 completely inhibited substrate phosphorylation, whereas SU6656 did not. The difference may be ascribed to 2-y reactivity toward other kinases whose activities were not inhibited by SU6656. We next applied our peptide array to a model experiment for cell-based drug screening. Different concentrations of pp2 and SU6656 were incubated with MCF-7 cells, and inhibition was evaluated using the cell lysates (Fig. 3A) . The phosphorylation ratio of the substrate gradually decreased with increasing inhibitor concentrations. When compared with the results from drug screening with purified c-Src (Supplementary Fig. 2C ), SU6656 showed a stronger inhibition than pp2. This difference may be due to the different solubility, stability, and membrane permeability of the 2 inhibitors, and it also indicates the importance of cell-based drug screening, which enables one to assess compound potency, toxicity, and effectiveness in a real cellular environment.
Detection of the signal pathway-mediated fluctuation of kinase activity is crucial for the determination of cell function and oncogenic pathology. hence, we investigated whether our peptide array can detect the signal pathway-mediated subtle changes in kinase activity. It has been reported that the treatment of MCF-7 cells with pMA leads to c-Src activation 12 by a signal transduction as follows. First, pMA activates protein kinase Cδ, then protein kinase Cδ phosphorylates a phosphatase (pTpα) on its 2 serine residues, thereby shifting the phosphatase into an active conformation. Finally, pTpα dephosphorylates c-Src at Tyr-527, resulting in c-Src activation. 13 It was also reported that NGF stimulates c-Src activity by activation of a Trk tyrosine kinase receptor. 14 detect c-Src activation through these 2 different signal pathways, we stimulated MCF-7 cells with pMA or NGF, and the cell lysates were prepared for on-chip phosphorylation (Fig.  3B) . The phosphorylation ratio of substrate increased by about 20% after both NGF and pMA stimulation. This result verifies the previous result that 2-y has specificity for the c-Src kinase, and it also demonstrates that our peptide array can be applied for monitoring intracellular kinase activity fluctuation mediated through signal pathways.
Finally, we also succeeded in detecting c-Src activity in different cell lines (Fig. 3C) , as well as in mouse brain and skin tissues (Fig. 3D) , with our peptide array. These results demonstrate that our peptide array is sensitive enough to detect kinase activity in various cells, even in living tissue. This capacity is essential for diagnosis and drug discovery for various diseases.
We have succeeded in detecting intracellular protein kinase activity while most of the other peptide arrays are confined to only purified kinase-based studies. The successful detection of intracellular protein kinase activity using our peptide array may be ascribed to several aspects. The glass we used provides more than 2 times larger amino density (12 pieces/nm 2 ) than that of ApTeS (3-aminopropyltriethoxysilane)-modified glass (5 pieces/nm 2 ), 15 enabling much more peptide immobilization for sensitive detection. Our optimized experimental conditions, including linker kind for peptide immobilization, blocking agent, and washing step for reducing nonspecific adsorption, also make clear detection possible. The suitable lysis buffer and lysate-making method that are crucial for sustaining the protein activity can also be one of the reasons.
CONCLUSIONS
We have developed a high-throughput peptide array to evaluate kinase activity. This peptide array system needs low sample volume and provides high reproducibility. The peptide array could be applicable for inhibitor screening and substrate profiling using purified kinases. The successes of detecting c-Src activities in different cell lines as well as mouse tissues and monitoring small fluctuations of c-Src activity responded to various drug stimuli demonstrate that the sensitive peptide array can be potentially useful for kinase-targeted diagnosis, cell-based drug screening, and research on signal pathways.
